These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3955413)

  • 1. [Personal experience with monitoring the effects of heparin during cardiosurgical operations using artificial blood circulation].
    Sefránek V; Simkovic I; Barta E; Vrsanský D
    Bratisl Lek Listy; 1986 Mar; 85(3):305-14. PubMed ID: 3955413
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of heparin therapy in open-heart surgery.
    Jaberi M; Bell WR; Benson DW
    J Thorac Cardiovasc Surg; 1974 Jan; 67(1):133-41. PubMed ID: 4808908
    [No Abstract]   [Full Text] [Related]  

  • 3. Individual responses to heparinization for extracorporeal circulation.
    Friesen RH; Clement AJ
    J Thorac Cardiovasc Surg; 1976 Dec; 72(6):875-9. PubMed ID: 994537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
    Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
    Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding.
    Kaul TK; Crow MJ; Rajah SM; Deverall PB; Watson DA
    J Thorac Cardiovasc Surg; 1979 Jul; 78(1):95-102. PubMed ID: 449391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Artificial hypocoagulation during cardiosurgical operations and its monitoring].
    Charnaia MA; Morozov IuA; Gladysheva VG
    Anesteziol Reanimatol; 2006; (6):76-9. PubMed ID: 17288273
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with activated clotting time (ACT) controlled heparinization in open heart surgery.
    Albrechtsen OK; Stenbjerg S; Berg E
    Thorac Cardiovasc Surg; 1982 Apr; 30(2):109-12. PubMed ID: 6179241
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monitoring of metabolism during artificial blood circulation in open-heart surgery].
    Flerov EV; Shitikov II; Savel'ev SA; Georgievskaia EIu; Ban'kov AB
    Vestn Akad Med Nauk SSSR; 1990; (12):36-41. PubMed ID: 2291326
    [No Abstract]   [Full Text] [Related]  

  • 9. [Postoperative hemorrhage in cardiac surgery with extracorporeal circulation].
    Cachera JP; Kieffer E; Dubost C
    J Chir (Paris); 1970 Feb; 99(2):97-107. PubMed ID: 5419521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Haemochron--a simple method of monitoring heparin level during extracorporeal circulation].
    Saggau W; Lüllig H; Storch HH; Tanzeem A; Schmitz W; Hissen W
    Chir Forum Exp Klin Forsch; 1978; (1978):119-22. PubMed ID: 752575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of disseminated intravascular coagulation after intervention under extracorporeal circulation].
    Metras D; Delaye A; Fuentes P; Manuel C; Georges E
    Mars Med; 1972; 109(3):223-6. PubMed ID: 5046955
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin dosage in extracorporeal circulation and its neutralization.
    Nyman D; Thurnherr N; Duckert F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):102-4. PubMed ID: 1118825
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.
    Bull BS; Korpman RA; Huse WM; Briggs BD
    J Thorac Cardiovasc Surg; 1975 May; 69(5):674-84. PubMed ID: 1127966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin rebound in open heart surgery.
    Gollub S
    Surg Gynecol Obstet; 1967 Feb; 124(2):337-46. PubMed ID: 6016829
    [No Abstract]   [Full Text] [Related]  

  • 17. [The blood cogulation and fibrinolytic enzyme system during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Orv Hetil; 1970 May; 111(18):1027-30. PubMed ID: 5454001
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of the activated coagulation time (ACT) in open heart surgery--comparison between children and adult patients].
    Ohmi M; Tsuboi H; Furukawa S; Mohri H; Seo K
    Kyobu Geka; 1984 Nov; 37(12):945-8. PubMed ID: 6521115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemorrhages during cardiac surgery with extracorporeal circulation].
    Gascon P; Daussy M; Daumet P
    Ann Chir Thorac Cardiovasc; 1967 Jul; 6(3):323-7. PubMed ID: 5618385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.